DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹829 Cr | ₹1,891 Cr | ₹-376 Cr | ₹-2,686 Cr | ₹-242 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹829 Cr |
| Mar2025 | ₹1,891 Cr |
| Mar2024 | ₹-376 Cr |
| Mar2023 | ₹-2,686 Cr |
| Mar2022 | ₹-242 Cr |
How is Cash Flow from Financing Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹829 Cr | -56.16 | |
| Mar2025 | ₹1,891 Cr | Positive | |
| Mar2024 | ₹-376 Cr | Negative | |
| Mar2023 | ₹-2,686 Cr | Negative | |
| Mar2022 | ₹-242 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹96,324.4 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| MANKIND PHARMA | ₹96,179.6 Cr | -2.9% | -4.2% | -6.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.9% |
-1.8% |
-9.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses